Market Size (2025)
$17.61M
Vertical: CNMBase Year: 2025
Market Size (2025)
$17.61M
Projected (2032)
$27.12M
CAGR (2022–2032)
6.4%
Key Players
10+
Market Overview
The Global 2-Chloro-5-(Trifluoromethyl)pyridine Market was valued at USD 17.612 Million in 2025 and is projected to reach USD 27.121 Million by 2032, registering a CAGR of 6.35% over the forecast period 2026–2032. In absolute terms, the market is expected to add USD 9.509 Million between 2025 and 2032. Historically, the market expanded from USD 14.582 Million in 2022 to USD 17.612 Million in 2025, reflecting steady demand for trifluoromethylpyridine (TFMP) intermediates from the crop protection industry.
2-Chloro-5-(trifluoromethyl)pyridine (CAS No. 52334-81-3), commonly referred to in the industry as 2,5-CTF or 2-CTF, is a halogenated, fluorinated pyridine intermediate. It is the key building block for the aryloxyphenoxypropionate ("fop") grass herbicide fluazifop-butyl and its resolved isomer fluazifop-P-butyl, and it is also used in the synthesis of other TFMP-based agrochemicals such as the insecticide pyridalyl, as a precursor for 2,3-dichloro-5-(trifluoromethyl)pyridine (2,3,5-DCTF), and as a building block for pharmaceutical intermediates. Commercial production is concentrated in Asia Pacific, where integrated producers convert 3-picoline into 2,5-CTF through vapor-phase or liquid-phase chlorination and fluorination routes.
Key Findings
By Downstream Product: Fluazifop and Others each accounted for USD 8.806 Million (50.0% share) in 2025, giving the two segments equal positions in the base year. Others is the fastest-growing segment at a CAGR of 6.97%, compared with 5.70% for Fluazifop, and is projected to reach USD 14.130 Million by 2032.
By Purity: The 98% & Above segment is both the largest and the fastest-growing segment, valued at USD 14.090 Million (80.0% share) in 2025 and expanding at a CAGR of 6.81% to reach USD 22.361 Million by 2032.
By Region: Asia Pacific is the leading region with USD 13.737 Million (78.0% share) in 2025. Middle East & Africa is the fastest-growing region, with a CAGR of 8.34% over 2026–2032.
By Country: China is the leading country, with a market value of USD 7.968 Million in 2025. Saudi Arabia is the fastest-growing country, with a CAGR of 9.38%, followed by UAE at 9.24%. Within Asia Pacific, India records the highest growth at a CAGR of 8.89%.
Segmentation Summary
The market is segmented by downstream product (Fluazifop and Others) and by purity (98% & Above and Below 98%), and is analysed across five regions and their constituent countries. The summary table below identifies the largest and fastest-growing segment within each segmentation.
Competitive Landscape Summary
The market is moderately consolidated at the producer level. Ishihara Sangyo Kaisha (ISK) of Japan, which originated TFMP chemistry and commercialised fluazifop-butyl in 1982, remains the technology reference for vapor-phase TFMP production. A group of Chinese producers, including Shandong Huimeng Bio-Tech, Dalian Join King Fine Chemical with its Inner Mongolia affiliate, and Sinochem Lantian, supplies a large share of merchant volumes and is increasingly integrated forward into fluazifop-P-butyl and 2,3,5-DCTF derivatives. Downstream active ingredient owners such as Syngenta Group (fluazifop-P-butyl) and Sumitomo Chemical (pyridalyl) shape demand, while pyridine and picoline suppliers such as Jubilant Ingrevia, Aurorium and Koei Chemical influence raw material availability. Competition centres on process yield, product purity, environmental compliance and the ability to offer integrated supply from 3-picoline through to finished active ingredients.
Challenges and Opportunities
The principal challenges are environmental and safety compliance in chlorination and hydrogen fluoride (HF) fluorination operations, the consolidation of chemical production into designated industrial parks in China, volatility in 3-picoline and chlorine-derived input costs, and growing regulatory scrutiny of per- and polyfluoroalkyl substances (PFAS) and their degradation product trifluoroacetic acid (TFA) in Europe. Opportunities arise from the continued use of selective post-emergence grass herbicides in broadleaf crops, the expanding use of TFMP building blocks in newer agrochemicals and pharmaceuticals, supply diversification toward India, and demand for high-purity grades that command better margins.
Future Outlook
Between 2025 and 2032, the market is expected to grow from USD 17.612 Million to USD 27.121 Million. Asia Pacific will remain the production and consumption centre, adding USD 7.550 Million over the period, while Latin America (CAGR 7.54%) and Middle East & Africa (CAGR 8.34%) will grow faster from smaller bases. The 98% & Above purity grade will increase its share as downstream formulators tighten impurity specifications, and the Others downstream segment will gradually overtake Fluazifop as 2,5-CTF finds wider use in pyridalyl, DCTF-derived chemistries and pharmaceutical intermediates. Producers that combine process efficiency, environmental compliance and forward integration are expected to be best positioned over the forecast period.
The 2-Chloro-5-(Trifluoromethyl)pyridine Market market is projected to grow at a CAGR of 6.4% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
2-Chloro-5-(trifluoromethyl)pyridine (molecular formula C6H3ClF3N; CAS No. 52334-81-3) is a pyridine derivative carrying a chlorine atom at the 2-position and a trifluoromethyl (CF3) group at the 5-position of the pyridine ring. At ambient conditions it is a low-melting solid or colourless to pale yellow liquid. The chlorine atom at the 2-position is activated toward nucleophilic aromatic substitution, which allows the molecule to be coupled with phenols, amines and thiols; the CF3 group imparts lipophilicity, metabolic stability and biological activity to the final molecule.
Commercially, the compound is produced from 3-picoline (3-methylpyridine) by one of two main routes: a vapor-phase route in which 3-picoline is simultaneously chlorinated and fluorinated at high temperature over metal fluoride catalysts to produce 3-(trifluoromethyl)pyridine, followed by ring chlorination; or a liquid-phase route through 2-chloro-5-methylpyridine and 2-chloro-5-(trichloromethyl)pyridine, followed by halogen exchange with anhydrous hydrogen fluoride.
For the purpose of this study, the market includes the merchant and captive value of 2-chloro-5-(trifluoromethyl)pyridine sold or transferred for use in the manufacture of fluazifop-butyl and fluazifop-P-butyl and for other downstream uses, across purity grades of 98% & Above and Below 98%. The market excludes the value of finished active ingredients and formulated herbicides, the value of upstream raw materials such as 3-picoline, chlorine and hydrogen fluoride, and other TFMP isomers and derivatives such as 2,3-dichloro-5-(trifluoromethyl)pyridine and 2-chloro-3-(trifluoromethyl)pyridine when sold as separate products.
Scope of the Study
Segmentation by Downstream Product: Fluazifop; Others
Segmentation by Purity: 98% & Above; Below 98%
Regions: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Countries: U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Rest of Europe, China, India, Japan, Rest of Asia Pacific, Brazil, Argentina, Rest of Latin America, UAE, Saudi Arabia, South Africa, Rest of MEA
Timeline: Historic years 2022–2024; base year 2025; forecast period 2026–2032
Currency/Unit: USD Million
Research Objectives
To estimate the size of the global 2-chloro-5-(trifluoromethyl)pyridine market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by downstream product (Fluazifop and Others) and quantify the demand linked to fluazifop-butyl and fluazifop-P-butyl production.
To assess the market by purity grade and the shift toward 98% & Above material for active ingredient synthesis.
To evaluate regional and country-level demand across North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges affecting TFMP intermediate supply and demand, including raw material, environmental and regulatory factors.
To examine the value chain from 3-picoline and fluorine chemicals through to herbicide and other downstream applications.
To profile the competitive environment, including leading producers, downstream active ingredient owners and upstream suppliers, and track developments since 2022.
To provide a forward-looking view of the market to support investment, sourcing and capacity planning decisions.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured, multi-stage research process. It began with the definition of the market scope and segmentation, followed by extensive secondary research to build an understanding of the product, its production technologies, downstream uses and the competitive environment. Primary research was then conducted with participants across the value chain to validate assumptions and refine estimates. Market size was derived using both top-down and bottom-up approaches, and the results were triangulated before forecasts were developed for 2026–2032. The final numbers were reviewed for internal consistency across segments, regions and countries.
Secondary Research
Secondary research drew on sources relevant to fluorinated pyridine intermediates and the crop protection industry, including:
Industry associations: CropLife International and regional crop protection associations, the China Crop Protection Industry Association (CCPIA), the Pesticide Manufacturers & Formulators Association of India (PMFAI) and fluorochemical industry bodies.
Government and regulatory bodies: the U.S. Environmental Protection Agency (EPA) pesticide registration review dockets, the European Commission EU Pesticides Database, the European Food Safety Authority (EFSA), the European Chemicals Agency (ECHA), China's Ministry of Agriculture and Rural Affairs (MARA) and Institute for the Control of Agrochemicals (ICAMA), and India's Central Insecticides Board and Registration Committee (CIBRC).
Company filings: annual reports, investor presentations, mid-term business plans and environmental impact assessment disclosures of producers and active ingredient owners.
Trade journals and technical literature: the Journal of Pesticide Science, agrochemical trade news services, patent databases covering TFMP process technology, and chemical industry periodicals.
Trade and statistical databases: customs and trade statistics for heterocyclic nitrogen compounds, and paid databases covering chemical prices, capacity and agrochemical sales.
Primary Research
Primary research consisted of in-depth interviews and structured discussions with industry participants on both the supply and demand sides. On the supply side, respondents included production and business development managers at TFMP intermediate manufacturers, pyridine and picoline suppliers, fluorochemical producers and distributors of fine chemical intermediates. On the demand side, respondents included procurement and technical managers at active ingredient manufacturers, formulators of fluazifop-based herbicides, and contract manufacturers serving the agrochemical and pharmaceutical sectors. The objectives of primary research were to validate market size and segment splits, understand pricing and purity requirements, identify capacity changes and supply constraints, and gather qualitative insights into growth drivers and competitive dynamics.
Market Size Estimation
Top-down approach: The demand for 2-chloro-5-(trifluoromethyl)pyridine was derived from the consumption of downstream active ingredients, principally fluazifop-butyl and fluazifop-P-butyl, using stoichiometric conversion factors and typical process yields, and then extended to other downstream uses. Regional and country splits were assigned based on active ingredient production locations, crop protection consumption and trade flows.
Bottom-up approach: Production capacities, utilisation rates and output of identified producers were compiled and multiplied by prevailing average selling prices for each purity grade. Captive consumption was valued at merchant-equivalent prices.
Data triangulation: The results of the two approaches were compared and reconciled with inputs from primary research, price trends and trade data. Differences were investigated and resolved to arrive at the final market estimates for each segment, region and country.
Forecasting Methodology
Forecasts for 2026–2032 were built from the base-year estimates using a combination of demand-side and supply-side indicators. Factors considered include the outlook for crop protection demand in broadleaf crops such as soybean, cotton, canola, sugar beet and vegetables; the regulatory status of fluazifop-P-butyl and other downstream active ingredients; capacity additions and closures among intermediate producers; raw material availability and pricing for 3-picoline, chlorine and hydrogen fluoride; environmental policy in major producing countries; and the adoption of TFMP building blocks in new agrochemical and pharmaceutical molecules. Growth rates were applied at the segment and country level and aggregated to regional and global totals.
Base Year, Forecast Period and Currency
Base year: 2025
Historic period: 2022–2024
Forecast period: 2026–2032
Currency: USD Million (values are expressed in nominal terms)
Assumptions and Limitations
The regulatory approvals of the principal downstream active ingredients remain in force across major markets over the forecast period, with no outright bans in key consuming regions.
No major disruption to global supplies of 3-picoline, chlorine or anhydrous hydrogen fluoride occurs beyond normal cyclical variations.
Exchange rates are assumed to remain broadly stable relative to the base year; values are not adjusted for inflation.
Captive production by integrated manufacturers is valued at merchant-equivalent prices, which may differ from internal transfer prices.
Detailed production data for private producers, particularly in China, are limited; estimates for these companies rely on capacity disclosures, environmental filings and primary research.
Market estimates may be affected by unforeseen events such as plant incidents, trade restrictions or sudden changes in agricultural demand.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global 2-Chloro-5-(Trifluoromethyl)pyridine Market is moderately consolidated. The number of companies with the process technology, environmental permits and integrated raw material supply needed to produce 2,5-CTF at commercial scale is limited, and production is concentrated in Japan and China. Ishihara Sangyo Kaisha (ISK), which developed the vapor-phase TFMP process and commercialised fluazifop-butyl, remains the technology reference, while Chinese producers such as Shandong Huimeng Bio-Tech, Dalian Join King Fine Chemical with its Inner Mongolia affiliate, and Sinochem Lantian supply a large share of merchant and captive volumes.
Competition is shaped by three groups of participants: producers of the intermediate, downstream active ingredient owners whose products determine demand, and upstream pyridine and picoline suppliers that control the key raw material. The nature of competition is based on process yield and selectivity, product purity, cost, environmental compliance and reliability of supply. Forward integration into fluazifop-P-butyl, haloxyfop-P-methyl and 2,3,5-DCTF, and long-term supply agreements with multinational active ingredient owners, are the main sources of competitive advantage. Contract manufacturing in India is emerging as an alternative source of agro-intermediates for multinational buyers seeking supply diversification.
Key Player Positioning
Based on technology capability, integration, product portfolio and market reach, the leading companies in the market are positioned as follows:
Leaders: Ishihara Sangyo Kaisha (originator of TFMP chemistry and fluazifop-butyl, with proprietary vapor-phase process know-how); Syngenta Group (owner of the Fusilade fluazifop-P-butyl franchise and the largest demand anchor for the intermediate); Shandong Huimeng Bio-Tech (integrated Chinese producer of 2,5-CTF, 2,3,5-DCTF, fluazifop-P-butyl and haloxyfop-P-methyl).
Challengers: Dalian Join King Fine Chemical / Inner Mongolia Join Dream Fine Chem (producer of 2,5-CTF, 2,3,5-DCTF and related TFMP intermediates); Sinochem Lantian (holder of gas-phase 2,5-CTF and DCTF process patents, backed by the Sinochem group); Jubilant Ingrevia (large non-Chinese pyridine and picoline producer expanding into agro-intermediate contract manufacturing).
Niche players: Sumitomo Chemical (owner of pyridalyl, a specialised downstream use of 2,5-CTF); Koei Chemical (pyridine-base and nitrogen-heterocycle specialist, now part of Sumitomo Chemical); Aurorium (pyridine and picoline supplier with production in China).
Competitor Dashboard
The competitor dashboard rates each profiled company on product portfolio, regional presence, strategic alliances and industry experience relative to this market.
Threat of New Entrants: Low
Production requires proprietary chlorofluorination know-how, high-temperature reactors and corrosion-resistant equipment for handling HF and chlorine.
Environmental permitting and the requirement to locate in approved chemical parks in China and India raise entry barriers.
Incumbents benefit from integration with picoline supply and downstream active ingredient production.
Bargaining Power of Suppliers: Medium
3-Picoline supply is concentrated among a small number of pyridine producers, mainly in Asia.
Chlorine and hydrogen fluoride are widely available commodities, but logistics and safety requirements limit flexibility.
Integrated producers with captive picoline or HF reduce supplier leverage.
Bargaining Power of Buyers: Medium
Large active ingredient owners and generic fluazifop producers purchase significant volumes and negotiate long-term contracts.
Purity specifications and registration-linked supplier qualification make switching suppliers time-consuming, which limits buyer leverage.
Captive consumption by integrated producers reduces the share of merchant volumes exposed to buyer negotiation.
Threat of Substitutes: Low
There is no direct substitute for 2,5-CTF in the synthesis of fluazifop-butyl and pyridalyl.
Substitution occurs only at the end-product level, where growers may use alternative graminicides such as clethodim or quizalofop.
Alternative routes to the same TFMP intermediate do not change demand for the product itself.
Intensity of Competitive Rivalry: Medium
A moderate number of producers compete, with Chinese manufacturers competing on cost and scale.
Competition focuses on yield, purity, environmental compliance and reliability of supply.
Forward integration into actives and derivatives differentiates leading players.
Threat of New Entrants: Low.
Bargaining Power of Suppliers: Medium.
Bargaining Power of Buyers: Medium.
Threat of Substitutes: Low.
Intensity of Competitive Rivalry: Medium.
Market estimates by geography (2032)
InsightAsia Pacific leads with $21.29M by 2032, while Middle East & Africa is projected to grow fastest at a 8.3% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $0.92M | $1.17M | $1.48M | 4.9% | 5% |
| Europe | $1.22M | $1.56M | $1.98M | 5.0% | 7% |
| Asia Pacific | $11.31M | $15.59M | $21.29M | 6.5% | 78% |
| Latin America | $0.85M | $1.22M | $1.76M | 7.5% | 6% |
| Middle East & Africa | $0.28M | $0.41M | $0.62M | 8.3% | 2% |
| Total | $14.58M | $19.95M | $27.12M | 6.4% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$27.12M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Others | $14.13M | 7.1% | 52% |
| Fluazifop | $12.99M | 5.7% | 48% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on 2-Chloro-5-(Trifluoromethyl)pyridine Market covering market dynamics, competitive landscape, and strategic outlook.
The 2-Chloro-5-(Trifluoromethyl)pyridine Market market is projected to reach $27.12M by 2032, growing at 6.4% CAGR. The Others segment holds the largest share.
The Global 2-Chloro-5-(Trifluoromethyl)pyridine Market is shaped by the demand for selective grass herbicides and other TFMP-based crop protection chemicals, by the availability and cost of pyridine-based raw materials and fluorine chemicals, and by the regulatory environment governing both chemical manufacturing and pesticide use. This chapter assesses the macro and micro factors influencing the market and describes the principal drivers, restraints, opportunities, trends and challenges. The impact scores presented in the growth factor analysis are analyst assessments, based on secondary research and industry discussions, of the relative influence of each factor on market growth over three forecast windows, on a scale of 1 (minimal impact) to 10 (very high impact).
Sustained Demand for Selective Post-Emergence Grass Herbicides
Fluazifop-P-butyl, the principal downstream product of 2-chloro-5-(trifluoromethyl)pyridine, is an ACCase-inhibiting aryloxyphenoxypropionate herbicide that selectively controls annual and perennial grass weeds in broadleaf crops. It is used in soybean, cotton, canola, sugar beet, potatoes, vegetables, fruit orchards and plantation crops, and is sold under established brands such as Syngenta's Fusilade as well as by numerous generic suppliers. The herbicide's value lies in its crop selectivity: it allows farmers to remove volunteer cereals and grass weeds from broadleaf crops without damaging the crop itself. As growers in the Americas, Europe and Asia continue to rotate broadleaf crops with cereals and seek post-emergence options that complement pre-emergence programmes, demand for fluazifop-based products remains stable. Each tonne of fluazifop-P-butyl requires a defined quantity of 2,5-CTF, which creates a direct and predictable link between herbicide consumption and intermediate demand. The continued presence of generic fluazifop producers in China and India further supports volume demand for the intermediate.
Expanding Role of Trifluoromethylpyridine Chemistry in Agrochemical Innovation
Trifluoromethylpyridine moieties have become one of the most productive structural motifs in modern crop protection chemistry. Since ISK commercialised fluazifop-butyl in 1982 as the first TFMP-containing agrochemical, the motif has been incorporated into a range of herbicides, insecticides and fungicides, and technical literature from TFMP originators identifies a growing number of commercial TFMP-based active ingredients. 2-Chloro-5-(trifluoromethyl)pyridine is used directly in pyridalyl, Sumitomo Chemical's insecticide for lepidopteran and thrips control, and serves as a precursor for 2,3-dichloro-5-(trifluoromethyl)pyridine, which feeds haloxyfop, fluazinam, chlorfluazuron and fluopyram chemistries. The CF3 group enhances lipophilicity and metabolic stability, which improves biological efficacy at low application rates. As agrochemical companies continue to seek molecules with novel modes of action and favourable use rates, the availability of reliable, high-purity TFMP building blocks supports both established products and pipeline development, broadening the demand base for 2,5-CTF beyond fluazifop.
Capacity Investment and Forward Integration in Asia
Producers in China have invested in integrated TFMP production chains that start with chlorinated picoline intermediates and extend through 2,5-CTF and 2,3,5-DCTF to finished active ingredients. In March 2024, the China Crop Protection Industry Association reported plans by Shandong Huimeng Bio-Tech for a 1,500 tonnes per year fluazifop-P-butyl and 3,000 tonnes per year haloxyfop-P-methyl project, together with a technical upgrade of its DCTF-series facilities that includes 450 tonnes per year of 2,5-CTF capacity. Patent activity by Sinochem Lantian and the Zhejiang Research Institute of Chemical Industry on gas-phase 2,5-CTF processes and on converting 2,5-CTF to DCTF demonstrates continued investment in process technology. In India, Jubilant Ingrevia commissioned a multipurpose agro actives and intermediates plant at Bharuch in 2024 and secured a multi-year agro-intermediate supply contract. These investments expand the supply base, improve process yields and support the market's growth trajectory.
Growth of Agrochemical Manufacturing in India and Latin American Crop Demand
India has emerged as an important centre for agrochemical active ingredient and intermediate manufacturing, supported by a large domestic crop protection market, an established fine chemicals base and multinational efforts to diversify supply chains away from single-country sourcing. Industry associations have called for production-linked incentives to reduce reliance on imported technical-grade products, signalling policy interest in deepening domestic intermediate production. At the same time, Latin America, led by Brazil and Argentina, continues to expand soybean and other broadleaf crop areas, sustaining demand for graminicides such as fluazifop-P-butyl. Together, these trends support above-average growth in India and in Latin America, which are among the faster-growing geographies in this market over 2026–2032.
High-Purity Grades for Active Ingredient and Pharmaceutical Synthesis
Downstream manufacturers increasingly require 2,5-CTF with tightly controlled isomer and over-chlorinated impurity profiles to meet active ingredient specifications and registration requirements. The 98% & Above segment is projected to grow at a CAGR of 6.81%, faster than the overall market. Producers that invest in purification technology, such as the distillation and crystallisation processes described in recent patents, can capture a premium and secure long-term supply agreements with active ingredient owners and pharmaceutical intermediate makers.
Supply Diversification and Contract Manufacturing
Multinational agrochemical companies are seeking second sources for critical intermediates outside a single producing country. This creates opportunities for Indian fine chemical producers and contract development and manufacturing organisations (CDMOs) with pyridine chemistry capabilities to enter TFMP intermediate production, supported by long-term offtake agreements of the type signed by Jubilant Agro Sciences in October 2024.
Value Addition Through Downstream Derivatives
2,5-CTF can be converted into 2,3,5-DCTF and into 2-amino-, 2-hydroxy- and 2-mercapto-5-(trifluoromethyl)pyridine building blocks. Producers that integrate forward into these derivatives, or into finished actives such as fluazifop-P-butyl, can improve asset utilisation, capture additional margin and reduce exposure to merchant price cycles. Process routes that chlorinate 2,5-CTF to DCTF under pressure provide flexibility to shift output between products according to demand.
Stringent Environmental and Safety Requirements for Halogenation and Fluorination
The production of 2-chloro-5-(trifluoromethyl)pyridine involves chlorine gas, anhydrous hydrogen fluoride and high-temperature vapor-phase reactions, generating hydrochloric acid, chlorinated by-products and fluoride-bearing waste streams. Environmental inspections in China since 2017, combined with the 14th Five-Year pesticide industry plan that calls for fewer producers and relocation into designated chemical parks, have increased compliance costs and periodically constrained output. Smaller producers that cannot invest in waste treatment and safety systems face closure or consolidation, which can tighten supply and raise prices for downstream users.
Regulatory Pressure on Downstream Active Ingredients
Demand for the intermediate depends on the continued registration of its downstream products. Fluazifop-P is undergoing renewal assessment in the European Union, where its approval period has been extended pending completion of the review, and fluazifop-P-butyl remains in registration review with the U.S. EPA. In Europe, CF3-containing pesticides are attracting scrutiny because they can degrade to trifluoroacetic acid, a persistent compound found in groundwater, and some member states have already withdrawn products containing other CF3-bearing actives. Any restriction on fluazifop-P or other TFMP-based actives in major markets would directly reduce demand for 2,5-CTF.
Raw Material Concentration and Price Volatility
3-Picoline, the starting material for 2,5-CTF, is produced alongside pyridine by a limited number of manufacturers, with capacity concentrated in China and India. The closure of Aurorium's Indianapolis pyridine and picoline plant in 2023 removed the only production of its kind in the Western Hemisphere, increasing dependence on Asian supply. Fluctuations in picoline, chlorine and HF prices therefore feed directly into intermediate production costs and margins.
Shift to Vapor-Phase, Continuous Processes
Producers are moving from multi-step liquid-phase routes toward continuous vapor-phase chlorofluorination of 3-picoline, which offers fewer steps, lower waste generation and the ability to recycle over-chlorinated by-products by hydrogenolysis. Patented gas-phase processes report substantially improved selectivity toward 2,5-CTF.
Consolidation of Pyridine and TFMP Supply Chains
The pyridine industry has consolidated, with production capacity concentrated in Asia, and Sumitomo Chemical's move in 2026 to make Koei Chemical a wholly owned subsidiary illustrates the interest of agrochemical groups in securing nitrogen-heterocycle capabilities. Vertical integration from picoline to active ingredient is becoming a competitive requirement.
PFAS and TFA Scrutiny
Regulators and non-governmental organisations in Europe are paying increasing attention to fluorinated pesticides as sources of trifluoroacetic acid in water. Although regulatory definitions and outcomes remain under discussion, this trend is a long-term challenge for CF3-containing actives and may influence product portfolios and registration strategies.
Herbicide Resistance Management
Resistance to ACCase-inhibiting herbicides in several grass weed species is a challenge for fluazifop-P-butyl. The industry response, which includes mixtures and stewardship programmes, supports continued use but may limit growth in regions with widespread resistance.
The value chain of the Global 2-Chloro-5-(Trifluoromethyl)pyridine Market extends from basic petrochemical and inorganic inputs to finished crop protection and pharmaceutical products. Each stage is described below.
2-Chloro-5-(trifluoromethyl)pyridine is regulated both as an industrial chemical and, indirectly, through the registration of the pesticide active ingredients produced from it. Key regulations by major region are summarised below.
February 2022: Sinochem Lantian / Zhejiang Research Institute of Chemical Industry; Technology; Granted U.S. Patent US11254642B2 for a gas-phase process to produce 2-chloro-5-(trifluoromethyl)pyridine from 3-picoline via 3-(trifluoromethyl)pyridine.
March 2023: Vertellus (Aurorium); Acquisition / Rebranding; Rebranded as Aurorium and acquired Centauri Technologies, expanding its specialty chemicals portfolio.
August 2023: Aurorium; Capacity Rationalisation; Announced closure of its Indianapolis pyridine and picoline plant, effective October 2023, consolidating pyridine production in its plants in China.
March 2024: Jubilant Ingrevia (Jubilant Agro Sciences); Expansion; Commissioned a multipurpose agro actives and intermediates plant at Bharuch, Gujarat.
March 2024: Shandong Huimeng Bio-Tech; Expansion; Announced a 1,500 tonnes per year fluazifop-P-butyl and 3,000 tonnes per year haloxyfop-P-methyl project, along with a technical upgrade of its DCTF-series plant that includes 450 tonnes per year of 2-chloro-5-(trifluoromethyl)pyridine capacity.
May 2024: Ishihara Sangyo Kaisha; Strategy; Launched its "Vision 2030 Stage II" mid-term management plan for FY2024–FY2026, including capital expenditure and funds for M&A and in-licensing in agrochemicals.
October 2024: Jubilant Ingrevia (Jubilant Agro Sciences); Partnership / Contract; Signed a multi-year agro-intermediate supply contract with a global agrochemical company, with expected revenue of about USD 300 million.
February 2025: Sinochem Lantian / Zhejiang Research Institute of Chemical Industry; Technology; Granted U.S. Patent US12221415B2 for producing 2,3-dichloro-5-(trifluoromethyl)pyridine by chlorination of 2-chloro-5-(trifluoromethyl)pyridine.
March 2026: Jubilant Ingrevia (Jubilant Agro Sciences); Contract Execution; Commenced commercial supplies under its multi-year agro-intermediate contract with a global agrochemical company.
May 2026: Sumitomo Chemical / Koei Chemical; Acquisition; Announced a share exchange to make Koei Chemical, a pyridine-base producer, a wholly owned subsidiary, effective August 2026.
Political
Industrial policy in China favours consolidation of pesticide producers and relocation to chemical parks, shaping the supply base.
Supply chain security concerns in the U.S., Europe and India encourage diversification of critical agrochemical intermediate sources.
Trade measures on chemical intermediates and active ingredients can alter regional cost competitiveness.
Economic
Agricultural commodity prices and farm incomes influence herbicide spending and, in turn, intermediate demand.
3-Picoline, chlorine and HF price movements directly affect production costs.
Currency movements between the Chinese yuan, Indian rupee, Japanese yen and U.S. dollar affect export pricing.
Social
Growing food demand and the need for higher yields support the use of crop protection products.
Public concern about pesticide residues and environmental persistence increases pressure on fluorinated chemistries.
Technological
Vapor-phase chlorofluorination and catalytic ring chlorination improve yield and reduce waste.
Purification advances enable higher-purity grades for active ingredient and pharmaceutical use.
Continued discovery of TFMP-containing actives widens the application base.
Environmental
Chlorination and fluorination generate acidic and halogenated waste streams requiring treatment.
Scrutiny of TFA formation from CF3-containing pesticides may influence future product approvals in Europe.
Legal
Pesticide registration and renewal processes in the EU and U.S. determine market access for downstream products.
Chemical safety laws such as REACH, TSCA and China's hazardous chemical regulations govern production and trade of the intermediate.
Profiles of 102 companies operating in the 2-Chloro-5-(Trifluoromethyl)pyridine Market market, including revenue, employee count, and market positioning where available.
Showing 102 of 102 companies
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
RPM International is a holding company for more than a dozen semi-autonomous specialty-chemicals franchises. These businesses make coatings, sealants, roofing, concrete admixtures, flooring, fireproofing and building-envelope systems, mostly for maintenance, repair and restoration rather than new construction. Its brand portfolio is unusually deep for a USD 7.9 billion company: Rust-Oleum, DAP, Zinsser, Varathane and The Pink Stuff on the consumer side; Tremco, Euclid, Dryvit, Nudura, Kalzip, Stonhard, Carboline and Fibergrate on the professional side. Each brand holds a leading position in a niche that larger diversified coatings groups do not dominate. Since 2018 RPM has run successive operational-improvement programs (MAP to Growth, MAP 2025, and now "MAP 3.0"). These have lifted gross margin from about 36% (FY2022) to about 41% (FY2026) and moved the group from a loose federation toward a centrally coordinated operating company. RPM is a disciplined, dividend-growing compounder with 52 consecutive annual dividend increases. Its growth vectors are engineered building systems, emerging markets (the "Platform" model) and bolt-on M&A. --- ### Company's own description (FY2026 Form 10-K, Item 1) RPM describes itself as follows: its subsidiaries manufacture, market and sell specialty chemical product lines, including high-quality specialty paints, infrastructure rehab and repair products, protective coatings, roofing systems, sealants and adhesives. These products focus on the maintenance and improvement needs of the construction, industrial, specialty and consumer markets. Footprint as of 31 May 2026: - Products marketed in about 167 countries and territories. - Manufacturing in about 120 locations across 22 countries. - About 31% of sales generated internationally: foreign operations 29.8% of net sales, plus direct U.S. exports of 0.9%. The press-release boilerplate calls RPM "a world leader in specialty coatings, sealants, building materials and related services." ### Business model RPM's model has four defining features. - **Decentralised entrepreneurial structure, becoming more integrated.** The founder's philosophy, still quoted in the 2026 proxy, is: "Hire the best people you can find. Create an atmosphere that will keep them. Then let them do their jobs." Operating companies historically kept their own brands, sales forces and ERP systems. The MAP programs are deliberately centralising procurement, manufacturing, accounting and IT. The stated goal is to consolidate more than 75 ERP systems to one platform per segment (Q4 FY2026 8-K). **Repair and maintenance bias:** Much of the portfolio serves existing assets: roof restoration, re-cover, concrete repair, corrosion control, rust prevention and DIY touch-up. That demand is less cyclical than new-build construction. The FY2026 10-K notes that re-roofing has historically accounted for over three-quarters of U.S. roofing demand. **Systems and turnkey selling:** In CPG and PCG, RPM increasingly sells integrated systems (the "Power of One" building envelope) and supply-and-apply turnkey services. Examples include Stonhard flooring installation and Weatherproofing Technologies roofing services. This captures more of each construction project's spend. **Bolt-on M&A plus organic growth:** RPM completed six acquisitions in each of FY2025 and FY2026 (FY2026 10-K Note F). ### Revenue model mix RPM does not disclose a product versus service versus licensing split. From filings, the mix is: ### Value-chain position RPM is a formulator and brand owner, positioned downstream of commodity chemical producers. It buys petroleum-derived resins, solvents, pigments, minerals, metals and packaging (FY2026 10-K, Raw Materials). It is selectively backward-integrated: RPM cites expanding in-house raw material production, and Arnette Polymers makes amine curing agents and epoxy intermediates. Channels downstream include: - Mass merchants and home centres, where the single largest Consumer customer was 20% of Consumer sales in FY2026. - Hardware and paint stores. - Distributors. - Contractors and specifiers. - Direct sales to industrial plant owners, public institutions and infrastructure agencies. ### Independent characterisation RPM is best understood as a portfolio of niche category leaders with a structural margin-improvement story layered on top. The professional segments (CPG and PCG) are about 66% of sales and supply the growth. In FY2026 they posted record results driven by high-performance buildings, data centres, infrastructure, fireproofing and concrete admixtures. In Q1 FY2027, emerging-market regions grew more than 20%. The Consumer segment is about 34% of sales. It is a cash-generative but volume-challenged DIY business. Organic Consumer sales fell 0.8% in Q4 FY2026 and 4.7% in Q2 FY2026. They recovered to +5.2% in Q1 FY2027 on shelf-space wins and pricing. The equity debate therefore centres on three questions: 1. Can MAP savings and pricing protect margins against renewed raw-material inflation linked to the Middle East conflict? 2. Is the Q1 FY2027 CPG slowdown temporary? 3. Will the 9 November 2026 investor day credibly frame the next margin plan?
Company Headquarters: Amsterdam, Netherlands Founded: 1994 Workforce: ~35,200 Company Working: Akzo Nobel N.V. operates its business by manufacturing products of various industries such as decorative paints, automotive & specialty coatings, industrial coatings, powder coating and marine, protective and yacht coatings. The automotive and specialty coatings segment of the business comprises products such as aerospace coatings, consumer electronics coatings, automotive OEM coatings, vehicle refinishes and sign finishes. Further, its industrial coatings segment offers products including coil and extrusion coatings, wood finishes, packaging coatings, and adhesives. The company owns more than 3,100 patents and has robust research and development capabilities which is evident from the fact that it has spent around USD 1.33 billion on research and development in last five years and possess five R&D centers. The brand portfolio offered by the company includes Dulux, Sikkens, International and Interpon and has a strong geographical presence in around 150 countries.
3 interactive charts drawn from the 2-Chloro-5-(Trifluoromethyl)pyridine Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global 2-Chloro-5-(Trifluoromethyl)pyridine Market By Purity
Global 2-Chloro-5-(Trifluoromethyl)pyridine Market By Downstream Product
Global 2-Chloro-5-(Trifluoromethyl)pyridine Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)